Literature DB >> 16971897

Molecular mechanisms of muscular dystrophies: old and new players.

Kay E Davies1, Kristen J Nowak.   

Abstract

The study of the muscle cell in the muscular dystrophies (MDs) has shown that mutant proteins result in perturbations of many cellular components. MDs have been associated with mutations in structural proteins, signalling molecules and enzymes as well as mutations that result in aberrant processing of mRNA or alterations in post-translational modifications of proteins. These findings have not only revealed important insights for cell biologists, but have also provided unexpected and exciting new approaches for therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16971897     DOI: 10.1038/nrm2024

Source DB:  PubMed          Journal:  Nat Rev Mol Cell Biol        ISSN: 1471-0072            Impact factor:   94.444


  122 in total

1.  β1D chain increases α7β1 integrin and laminin and protects against sarcolemmal damage in mdx mice.

Authors:  Jianming Liu; Derek J Milner; Marni D Boppart; Robert S Ross; Stephen J Kaufman
Journal:  Hum Mol Genet       Date:  2011-12-16       Impact factor: 6.150

Review 2.  What has the mdx mouse model of Duchenne muscular dystrophy contributed to our understanding of this disease?

Authors:  Jennifer Manning; Dervla O'Malley
Journal:  J Muscle Res Cell Motil       Date:  2015-02-11       Impact factor: 2.698

Review 3.  microRNAs and muscle disorders.

Authors:  Jian-Fu Chen; Thomas E Callis; Da-Zhi Wang
Journal:  J Cell Sci       Date:  2009-01-01       Impact factor: 5.285

4.  Basal lamina strengthens cell membrane integrity via the laminin G domain-binding motif of alpha-dystroglycan.

Authors:  Renzhi Han; Motoi Kanagawa; Takako Yoshida-Moriguchi; Erik P Rader; Rainer A Ng; Daniel E Michele; David E Muirhead; Stefan Kunz; Steven A Moore; Susan T Iannaccone; Katsuya Miyake; Paul L McNeil; Ulrike Mayer; Michael B A Oldstone; John A Faulkner; Kevin P Campbell
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-24       Impact factor: 11.205

5.  Transient receptor potential channel 6 regulates abnormal cardiac S-nitrosylation in Duchenne muscular dystrophy.

Authors:  Heaseung Sophia Chung; Grace E Kim; Ronald J Holewinski; Vidya Venkatraman; Guangshuo Zhu; Djahida Bedja; David A Kass; Jennifer E Van Eyk
Journal:  Proc Natl Acad Sci U S A       Date:  2017-11-29       Impact factor: 11.205

6.  Resveratrol induces expression of the slow, oxidative phenotype in mdx mouse muscle together with enhanced activity of the SIRT1-PGC-1α axis.

Authors:  Vladimir Ljubicic; Matthew Burt; John A Lunde; Bernard J Jasmin
Journal:  Am J Physiol Cell Physiol       Date:  2014-04-23       Impact factor: 4.249

Review 7.  Transcriptional networks regulating the costamere, sarcomere, and other cytoskeletal structures in striated muscle.

Authors:  Nelsa L Estrella; Francisco J Naya
Journal:  Cell Mol Life Sci       Date:  2013-11-12       Impact factor: 9.261

8.  Immunoproteasome in animal models of Duchenne muscular dystrophy.

Authors:  Chiao-Nan Joyce Chen; Ted G Graber; Wendy M Bratten; Deborah A Ferrington; LaDora V Thompson
Journal:  J Muscle Res Cell Motil       Date:  2014-06-17       Impact factor: 2.698

9.  Role of dystroglycan in limiting contraction-induced injury to the sarcomeric cytoskeleton of mature skeletal muscle.

Authors:  Erik P Rader; Rolf Turk; Tobias Willer; Daniel Beltrán; Kei-Ichiro Inamori; Taylor A Peterson; Jeffrey Engle; Sally Prouty; Kiichiro Matsumura; Fumiaki Saito; Mary E Anderson; Kevin P Campbell
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-13       Impact factor: 11.205

10.  A duchenne muscular dystrophy gene hot spot mutation in dystrophin-deficient cavalier king charles spaniels is amenable to exon 51 skipping.

Authors:  Gemma L Walmsley; Virginia Arechavala-Gomeza; Marta Fernandez-Fuente; Margaret M Burke; Nicole Nagel; Angela Holder; Rachael Stanley; Kate Chandler; Stanley L Marks; Francesco Muntoni; G Diane Shelton; Richard J Piercy
Journal:  PLoS One       Date:  2010-01-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.